Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue (¥)

Daiichi Sankyo revenue was ¥1.04 t in FY, 2021

Quarterly Revenue (¥)

FY, 2019FY, 2020FY, 2021
Revenue¥981.79 b¥962.52 b¥1.04 t
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021
Revenue¥249.24 b¥230.3 b¥277.5 b¥236.95 b¥243.2 b¥258.6 b¥264.07 b¥265.9 b¥281 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Daiichi Sankyo revenue breakdown by business segment: 6.2% from Healthcare (OTC) Products, 93.6% from Prescription Drugs and 0.2% from Other

Daiichi Sankyo revenue breakdown by geographic segment: 22.6% from North America, 13.3% from Europe, 53.4% from Japan and 10.7% from Other

FY, 2020FY, 2022FY, 2021
Healthcare (OTC) Products68.4 b64.7 b67.43 b
Other2.13 b2.2 b2.17 b
Prescription Drugs911.26 b977.98 b892.92 b
FY, 2020FY, 2022FY, 2021
Other95.27 b112.02 b96.09 b
North America183.08 b236 b191.65 b
Europe95.73 b138.62 b114.05 b
Japan607.71 b558.25 b560.73 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu